TP53 and B-cell chronic lymphocytic leukemia: In contrast, CK cases with 3 or 4 aberrations (low-CK and intermediate-CK, respectively) had a shorter survival (median OS of 4.3 years) only when accompanied by TP53 aberrations.26 These findings appear relevant for risk stratification of patients with CLL.